Afterload reduction with angiotensin-converting enzyme inhibitor may improve LV function in thalassaemia patients not only by optimizing ventriculo-arterial interaction [33], but perhaps also through diminishing LV dyssynchrony by reducing wall stress [34] and cardiac fibrosis [35]. This evidence concerns the gene ACE and thalassemia.